Release Date: 30/04/20 09:22 Summary: Extensive high-grade hits at depth Price Sensitive: Yes Download Document 6.56MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%